Original title: Analysis of the development status and competitive landscape of China's chain pharmacies industry in 2021, concentration and chain rate have further improved. "Picture"
1. Chain pharmacies classification
Chain pharmacies are one of the most important components of China's pharmaceutical retail industry today. Chain pharmacies are a single pharmacies with a common business philosophy, service standardization and a complete quality management system, connected by a variety of methods such as unified purchase or authorized franchise under the unified management of a chain headquarters to achieve unified, standardized and standardized business management, that is, to unite independent and scattered pharmacies to form a wider coverage for business. Chain pharmacies are mainly divided into the following three categories:
Chain pharmacies classification
Source: Public information sorting
2. Relevant policies of chain pharmacies industry
my country's policies encourage the development of chain pharmacies, continuously promote the improvement of industry concentration, and the trend of strong people being strong is obvious. In terms of pharmaceutical reform policies, the pharmacies' practicing pharmacies , grade, etc., have improved the operating threshold and bargaining power of pharmacies. The profits of small pharmacies have been further compressed and gradually withdrawn from the market. On the other hand, excellent leading chain pharmacies have rapidly expanded their scale through self-built, mergers and acquisitions, and their market share has increased significantly. In addition, in May 2021, the Medical Insurance Bureau and the Health Commission jointly issued the " dual-channel " policy, and some regions have accelerated the coordination of offline pharmacies and outpatient clinics. As the subsequent inclusion of African-national negotiations will lead to continuous outflow of prescriptions for patients in hospitals. While enjoying the passenger flow dividend of dual-channel varieties, it will also drive the growth of other varieties such as OTC and health products.
Related policies of chain pharmacies industry
Source: Public information sorting
3. Chain pharmacies industry chain
From the perspective of the industrial chain, chain pharmacies belong to the pharmaceutical distribution industry, but are not limited to the pharmaceutical industry. Chain pharmacies mainly sell drugs, but in addition to drug sales, chain pharmacies can also sell medical devices, health foods, cosmetics and daily necessities, etc. Therefore, its upstream links include pharmaceutical manufacturing, health food manufacturing, medical device manufacturing, etc., but the main position is still pharmaceutical manufacturing.
chain pharmacy industry chain
Source: Public information sorted
From the total sales of my country's new crown epidemic, after my country's new crown epidemic is gradually under control, according to statistics, in 2021, the total sales of drug products in my country's three major terminals (public hospitals, retail pharmacies, and public primary medical care) was 1774.7 billion yuan, a year-on-year increase of 8.0%.
Total drug sales in China from 2013 to 2021
Source: MiNei.com, compiled by Huajing Industry Research Institute
In terms of the number of retail pharmacies, according to statistics, the number of domestic retail pharmacies continued to increase by 32,000 compared with 2020 to 586,500. At the same time, the population of retail pharmacies in my country has declined steadily, down to 2,408 people in 2021 (2,573 people in 2020), and has seen "five consecutive declines" since 2017.
2010-2021 China's number of retail pharmacies and the population of all stores
Source: National Bureau of Statistics, "China Pharmacy" magazine, compiled by Huajing Industry Research Institute
III. Analysis of the current development status of China's chain pharmacies industry
1, number of chain pharmacies
From the perspective of the number of chain pharmacies in my country, according to the data from the National Drug Administration of , as of the end of September 2021, there were 606,500 licensed enterprises in the country, including 6,658 retail chain headquarters, an increase of 360 compared with 2020.
2013-2021, the number of chain pharmacies in China
Source: State Drug Administration, compiled by Huajing Industry Research Institute
2, the number and chain rate of chain pharmacies
With the rapid growth of the number of chain pharmacies, the chain rate of the retail pharmacies industry is also constantly increasing.The chain rate of pharmacies increased from 35% in 2011 to 57% in Q3 2021, but the degree of chainization of pharmacies in my country is still relatively low compared with developed countries. The chain rate of pharmacies in the United States in 2021 was 90%, and there is still room for further improvement in the chain rate of pharmacies in my country. In the future, with the continuous elimination of individual pharmacies and the acceleration of industry integration, the increase in chain rate is expected to further accelerate.
2011-2021, the number and chain rate of chain pharmacies in China
Source: State Food and Drug Administration, compiled by Huajing Industry Research Institute
3, sales of the top 100 chain pharmacies
According to statistics, the sales of the top 100 chain pharmacies in China increased to 246.3 billion yuan in 2021 (223 billion yuan in 2020), with a growth rate of 10.45%, significantly higher than the industry average growth rate of 3.21% in 2021, reflecting the advantageous effect of leading companies in the industry. However, as of the end of 2021, the sales of the top 100 chain companies still accounted for only 52.45% of the industry in total, and the top 10 companies accounted for only 27.56%. The leading companies did not yet have an absolute advantage and still have a lot of room for growth.
Sales of the top 100 chain pharmacies in China from 2015 to 2021 (billion yuan)
Source: National Bureau of Statistics, "China Pharmacy" magazine, compiled by Huajing Industry Research Institute
4, single store trend of physical pharmacies
In recent years, the number of physical pharmacies stores and sales scale in my country have continued to increase, but the revenue scale of single store has gradually declined. As of 2021, the unit price of physical pharmacies in my country was 969,000 yuan/plus. The reason for the decline is related to local pharmacies saturation, centralized procurement reduction of drug prices and e-commerce impact.
2015-2021 single store trend of physical pharmacies in China
Source: Public information sorting
5. Analysis of the competitive landscape of China's chain pharmacies industry
1, chain pharmacies sales Top201, chain pharmacies sales Top20html l2
According to the "Statistical Analysis Report on the Operation of Drug Distribution Industry in 2021" released by the Ministry of Commerce, the top 10 sales in my country in 2021 were 114.7 billion yuan, accounting for 21.1% of the total retail market in the country, the same as in 2020; the total sales of the top 20 were 139.2 billion yuan, accounting for 25.5% of the total retail market in the country, and 0.2 percentage points year-on-year after deducting incomparable factors; the top 3 sales were National Pharmacy , Dasanlin and the People.
Total sales of China's pharmaceutical retail enterprises in 2021 Top20
Source: "2021 Drug Distribution Industry Operation Statistical Analysis Report", Huajing Industry Research Institute compiled
2, the number of stores of leading listed companies (including franchise) compared with
In recent years, six A companies in my country have been A The expansion momentum of listed companies in stock chain pharmacies has not diminished, and the number of new stores has steadily increased. According to statistics, as of 2021, the number of stores (including franchise) (including franchise) (including franchise) has increased by 6.3 times compared with 2013, and the compound growth rate of the number of stores from 2015 to 2021 reached 26.7%. However, in terms of market share, the total number of stores of the six private listed companies only accounts for 6.65% of the total number of retail pharmacies, an increase from 5.35% in 2020, and still has a lot of room for improvement. In the future, listed companies are expected to continue to leverage the capital market to expand through mergers and acquisitions, self-construction, strict franchise and other methods to maintain a high increase in the number of stores.
2013-2022 H1 listed companies' stores change (home)
Source: Company announcements, compiled by Huajing Industry Research Institute
6. Analysis of the development trend of China's chain pharmacies industry
1. The market size of the pharmaceutical retail industry will be further expanded
1. 6
Under the joint action of many factors such as the continuous and stable growth of GDP, the stable increase in the consumption level of , the gradual tension of the population aging crisis, and the urbanization rate exceeding 65%. The new medical reform, the continuous improvement of the medical insurance protection level under the background of , my country's retail pharmacy industry will usher in a continuous development dividend, and the stable growth of the demand market has driven the continuous expansion of the industry scale. It is expected that the domestic chain pharmacy industry will continue to develop healthily in the next ten years and continuously refresh the scale of drug retail.
2. Industry integration accelerates, industry concentration and chain rate will be further improved
. Against the backdrop of the continuous advancement and implementation of core medical reform policies such as pharmaceutical division and prescription outflow, the drug market in the hospital will gradually flow out to social pharmacies. Therefore, social pharmacies are becoming more and more favored and paid attention to the capital market. In recent years, more and more chain pharmacies have entered the capital market through IPO listing, and strengthened the integration of industry mergers and acquisitions through secondary market financing. In the future, with the further improvement of industry concentration and continuous optimization of policies, the chain pharmacies industry will have better development opportunities.
3. Professional medical service capabilities will become an important market competitiveness for pharmaceutical retail enterprises in the future
. Since the purchase and use of drugs are closely related to the health and safety of consumers, retail pharmacies need to provide professional pharmacy guidance during the process of consumers purchasing drugs. At the same time, with the gradual implementation of relevant medical reform policies such as " medicine separate " and "prescription outflow", pharmaceutical retail companies are facing new opportunities and challenges. On the one hand, with the promotion of prescription outflow, a larger share of the prescription drug market will be transferred to chain pharmacies for sales. The growth and share of prescription drugs in the future will be the largest source of growth for pharmacies; on the other hand, due to the special nature of prescription drugs and industry regulatory requirements, prescription drugs must be sold through professional professional pharmacists before they can be sold. Therefore, chain pharmacies need to further improve talent reserves in terms of equipped pharmacies and providing prescription review services, and also propose higher pharmacies for the pharmacies' business capabilities. The special safety requirements for drug sales and the gradual implementation of relevant medical reform policies will promote pharmaceutical retail enterprises to continuously improve their professional medical service capabilities.
4. The advent of the "new retail" era will put higher requirements on the information management of pharmaceutical retail enterprises
With the advent of the "new retail" era, as a sub-industry of the retail industry, the pharmaceutical retail industry also needs to optimize consumer experience, expand the ability to provide value-added service to suppliers, and improve the company's own operating efficiency based on the collection, sorting and analysis of business process data such as consumer purchases, supplier procurement, and logistics distribution. This will put higher requirements on the information management of pharmaceutical retail enterprises.
Original title: Analysis of the development status and competitive landscape of China's chain pharmacies industry in 2021, concentration and chain rate have been further improved. "Picture"
Huajing Industry Research Institute conducted an in-depth analysis of the development status of China's chain pharmacies industry, upstream and downstream industrial chains, competitive landscape and key enterprises, etc., to minimize corporate investment risks and operating costs and improve corporate competitiveness; and use a variety of data analysis technologies to predict the industry's development trends so that enterprises can seize the market opportunities in a timely manner; for more detailed content, please pay attention to the "2022-2027 China Chain Pharmacy Industry Market Panoramic Assessment and Development Strategy Planning Report" published by Huajing Industry Research Institute.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-